Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ed Ajootian who wrote (4232)	2/28/2000 11:18:00 PM
From: rkrw	Read Replies (1) of 10280

Sepracor holds less than 18% of Versicor. Sepracor doesn't call the shots, but Tim Barberich does sit on their board as one member amongst nine. Versicor would be a very attractive IPO candidate in this market. Two drugs in the clinic and major partnerships with Novartis and PNU, they also have the magic word, "gene" they could parlay. $1B market cap wouldn't be out of the question in this frenzy (imo). Versicor is on Sepracor's books as a $2M investment, could equate to >$100M if and when they do IPO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next